Cancer News and Research

Latest Cancer News and Research

Tollbooth ventilation system effective in protecting workers from traffic air pollution

Although there is the potential for tollbooth workers at the Baltimore Harbor Tunnel to be exposed to high levels of cancer-causing air toxins emitted from the thousands of vehicles that pass under their nose, researchers from the Johns Hopkins Bloomberg School of Public Health found that the tollbooth ventilation system was effective in keeping air toxins out of the tollbooth and away from the workers.

5 May 2005

Scientists extend the lifespan of mice

Scientists at the University of Washington and their colleagues at other research centers have found a way to significantly extend the lifespan of mice while reducing the impact of the aging process. Their study, which will be published online by the journal Science on May 5, lends more credence to the free-radical theory of aging.

5 May 2005

After surgery check colon tumors for signs of syndrome, study suggests

A new study suggests that, after surgery, all colon tumors should be tested to learn if the patient may have an inherited syndrome that carries an extremely high risk of cancer. It also suggests that this prescreening can be done using a relatively inexpensive microscopy test already used in hospital pathology laboratories.

5 May 2005

Cancer hijacks normal wound-healing processes

Scientists have known for the last decade that a link exists between wound healing and cancer. For instance, in a 1994 experiment at the Lawrence Berkeley National Laboratory, chickens infected with a cancer virus developed tumors in areas of their body that had undergone wounding or scarring, while no tumors developed in infected areas that had not suffered wounding.

5 May 2005

New cervical cancer drug could be a bestseller

New data released yesterday says that a new vaccine that promises to protect against cervical cancer could offer wider resistance to the disease than previously thought.

5 May 2005

Britain recalls 35 more products with Para Red dye

Thirty five products contaminated with an illegal red dye Para Red, that has been linked to cancer, were recalled on Thursday by Britain's Food Standards Agency.

5 May 2005

Penn researchers demonstrate that a metabolic enzyme works through the tumor-suppressor protein p53 to control cellular replication

Researchers at the University of Pennsylvania School of Medicine have identified in normal cells that a common metabolic enzyme, which acts as a rheostat of cellular conditions, also controls cell replication.

4 May 2005

6,000 UK breast screenings to be reviewed because of concerns

Women who had breast cancer screening at a hospital in Essex are to have their records reviewed after "inconsistencies" were found.

4 May 2005

New study confirms 'wait and see' approach best for some prostate cancers

Men diagnosed with low-grade localized prostate cancer who opt not to undergo aggressive treatment for the disease are unlikely to die of the disease, even after 20 years, according to researchers in Connecticut.

4 May 2005

Researchers unravel how nature releases the torque built up in DNA at the molecular level

A Dutch led international team of researchers has unravelled how nature releases the torque built up in DNA at the molecular level. The researchers from Delft University of Technology, the Ecole Normale Supérieure in Paris and the Sloan-Kettering Institute in New York published their findings in the 31 March 2005 issue of Nature. An artistic impression of the enzyme at work is featured on the cover of this issue.

4 May 2005

Newly identified fly genes provide clue to tumour growth

Researchers from the Oxford University Department of Human Anatomy and Genetics have found a new class of genes that are critical for cell growth and may be involved in the uncontrolled growth that takes place in cancer. The discovery could provide a key to future tumour therapies.

4 May 2005

Vaccine developed at Rockefeller University boosts natural killer T cells in patients with cancer

A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.

4 May 2005

Diabetes appears to rob women of usual advantage in heart disease risk

For men, a heart attack increases the risk of dying from coronary heart disease more than diabetes does, but for women, diabetes is sometimes the greater threat, according to a new study (PDF) in the May 3, 2005, issue of the Journal of the American College of Cardiology.

4 May 2005

pSivida's BrachySil takes first step in regulatory programme leading to product approval

pSivida Limited has announced that current data from its lead cancer product BrachySil will be presented at this year's European Society for Therapeutic and Radiation Oncology Conference in Budapest on May 5, 2005. The conference is an opportunity to share and validate the Company's promising findings with an international scientific, clinical and industrial audience.

3 May 2005

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

Patients with advanced non–small-cell lung cancer (NSCLC) whose tumor cells contain extra copies of the epidermal growth factor receptor (EGFR) gene may be more likely to respond to the drug gefitinib (Iressa), and this high gene copy number may be an effective predictor of gefitinib efficacy, according to a new study in the May 4 issue of the Journal of the National Cancer Institute.

3 May 2005

Study examines influence of celebrity endorsements of cancer screening

More than one-half of adults surveyed nationwide had seen or heard celebrity endorsements of cancer screening tests, and more than one-fourth of those who had seen or heard an endorsement reported that it made them more likely to undergo the promoted screening test, according to a new study in the May 4 issue of the Journal of the National Cancer Institute.

3 May 2005

Scientists use tobacco plants to create antibodies against tumor cells

Scientists at Jefferson Medical College are using tobacco plants to produce monoclonal antibodies – tiny guided protein missiles – that can target and hunt down cancer cells. The plants promise to provide a cheaper, faster method of producing anticancer antibodies, raising hopes that the technology can one day be used in humans.

3 May 2005

Long-term outcomes promising for patients with localized, low-grade prostate cancer

A study that includes 20 years of follow-up does not support aggressive treatment for localized, low-grade prostate cancer, with data indicating a small risk of progression of this grade of cancer, according to a study in the May 4 issue of JAMA.

3 May 2005

Monitoring program has successfully identified a large number of previously unknown, serious and often-fatal drug reactions

A monitoring program developed by a Northwestern University researcher has successfully identified a large number of previously unknown, serious and often-fatal drug reactions associated with 15 commonly used drugs, including Plavix®, thalidomide and drug-coated cardiac stents.

3 May 2005

UK products recalled because of banned food dye

The presence of banned dye Para Red has been found in two products on supermarket shelves and has immediately prompted their withdrawal from the market.

3 May 2005

Cancer News and Research

Latest Cancer News and Research

Tollbooth ventilation system effective in protecting workers from traffic air pollution

Scientists extend the lifespan of mice

After surgery check colon tumors for signs of syndrome, study suggests

Cancer hijacks normal wound-healing processes

New cervical cancer drug could be a bestseller

Britain recalls 35 more products with Para Red dye

Penn researchers demonstrate that a metabolic enzyme works through the tumor-suppressor protein p53 to control cellular replication

6,000 UK breast screenings to be reviewed because of concerns

New study confirms 'wait and see' approach best for some prostate cancers

Researchers unravel how nature releases the torque built up in DNA at the molecular level

Newly identified fly genes provide clue to tumour growth

Vaccine developed at Rockefeller University boosts natural killer T cells in patients with cancer

Diabetes appears to rob women of usual advantage in heart disease risk

pSivida's BrachySil takes first step in regulatory programme leading to product approval

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

Study examines influence of celebrity endorsements of cancer screening

Scientists use tobacco plants to create antibodies against tumor cells

Long-term outcomes promising for patients with localized, low-grade prostate cancer

Monitoring program has successfully identified a large number of previously unknown, serious and often-fatal drug reactions

UK products recalled because of banned food dye

Cancer Research - Second Edition eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in